Advanced Therapy Medicinal Products - ATMPs - A case study in health economics: ChondroCelect 110/17/2015 ATMP - D.Dubois.
TiGenix, from IP to IPO Leuven 20 November 2008 Gil Beyen Co-founder & CEO TiGenix NV Michael van Eeno Director ING Corporate Finance.